新規登録 | ログイン | FAQ      [?] 

Current Clinical Pharmacology

最近発刊の雑誌の目次より: Current Clinical Pharmacology © Bentham Science Publishers
  • Validating Diagnostic Tests, Correct and Incorrect Methods, New Developments
    Current Clinical Pharmacology, Vol. 3, No. 2. (May 2008), pp. 70-76.
  • Pioglitazone and Rosiglitazone: Effects of Treatment with a Thiazolidinedione on Lipids and Non Conventional Cardiovascular Risk Factors
    Current Clinical Pharmacology, Vol. 3, No. 2. (May 2008), pp. 77-84.
  • Targeted Therapies in Breast Cancer: Established Drugs and Recent Developments
    Current Clinical Pharmacology, Vol. 3, No. 2. (May 2008), pp. 85-98.
  • Radiopharmaceuticals in Neurological and Psychiatric Disorders
    Current Clinical Pharmacology, Vol. 3, No. 2. (May 2008), pp. 99-107.
  • Enhancing the Cytotoxic Activity of Novel Targeted Therapies - Is There a Role for a Combinatorial Approach?
    Current Clinical Pharmacology, Vol. 3, No. 2. (May 2008), pp. 108-117.
    by Liu, M Wai
  • Efficacy and Safety Evaluation of Fixed Dose Combination of Cefepime and Amikacin in Comparison with Cefepime Alone in Treatment of Nosocomial Pneumonia Patients
    Current Clinical Pharmacology, Vol. 3, No. 2. (May 2008), pp. 118-122.
  • Amyloid Beta Protein and Tau in Cerebrospinal Fluid and Plasma as Biomarkers for Dementia: A Review of Recent Literature
    Current Clinical Pharmacology, Vol. 3, No. 2. (May 2008), pp. 123-131.
  • The Molecular Basis of Class Side Effects Due to Treatment with Inhibitors of the VEGF/VEGFR Pathway
    Current Clinical Pharmacology, Vol. 3, No. 2. (May 2008), pp. 132-143.
  • Preclinical and Clinical Efficacy of the Bisphosphonate Ibandronate in Cancer Treatment
    Current Clinical Pharmacology, Vol. 3, No. 1. (January 2008), pp. 1-10.
  • Current Pharmacological Treatment of Pulmonary Arterial Hypertension
    Current Clinical Pharmacology, Vol. 3, No. 1. (January 2008), pp. 11-19.
  • AZT: An Old Drug with New Perspectives
    Current Clinical Pharmacology, Vol. 3, No. 1. (January 2008), pp. 20-37.
  • Peripheral Benzodiazepine Receptor (PBR) New Insight in Cell Proliferation and Cell Differentiation Review
    Current Clinical Pharmacology, Vol. 3, No. 1. (January 2008), pp. 38-45.
  • Diagnosis and Treatment of Paraneoplastic Neurological Syndromes
    Current Clinical Pharmacology, Vol. 3, No. 1. (January 2008), pp. 46-50.
  • Clinical Pharmacology of Trastuzumab
    Current Clinical Pharmacology, Vol. 3, No. 1. (January 2008), pp. 51-55.
  • Enzyme Inhibition and Induction in Liver Disease
    Current Clinical Pharmacology, Vol. 3, No. 1. (January 2008), pp. 56-69.
  • Modulation of Fatty Acids Oxidation in Heart Failure by Selective Pharmacological Inhibition of 3-Ketoacyl Coenzyme-A Thiolase
    Current Clinical Pharmacology, Vol. 2, No. 3. (September 2007), pp. 190-196.
  • Chemotherapy and Delivery in the Treatment of Primary Brain Tumors
    Current Clinical Pharmacology, Vol. 2, No. 3. (September 2007), pp. 197-211.
  • The Rabbit Syndrome: State of the Art
    Current Clinical Pharmacology, Vol. 2, No. 3. (September 2007), pp. 212-216.
  • Applications of Artificial Neural Networks in Medical Science
    Current Clinical Pharmacology, Vol. 2, No. 3. (September 2007), pp. 217-226.
  • Drugs Treatment of Pain in Multiple Sclerosis
    Current Clinical Pharmacology, Vol. 2, No. 3. (September 2007), pp. 227-233.
  • The Pharmacokinetics and Pharmacodynamics of Levodopa in the Treatment of Parkinsons Disease
    Current Clinical Pharmacology, Vol. 2, No. 3. (September 2007), pp. 234-243.
  • A Review of the Immunosuppressive Activity of Cyclosporine Metabolites:New Insights into an Old Issue
    Current Clinical Pharmacology, Vol. 2, No. 3. (September 2007), pp. 244-248.
  • Old and New Antiepileptic Drugs for the Treatment of Idiopathic Generalized Epilepsies
    Current Clinical Pharmacology, Vol. 2, No. 3. (September 2007), pp. 249-259.
  • Dynamic Contrast-Enhanced MRI in Oncology Drug Development
    Current Clinical Pharmacology, Vol. 2, No. 2. (May 2007), pp. 111-122.
    by Margaret Cheng, Hai-Ling
  • Novel Procedures for Validating Surrogate Endpoints in Clinical Trials
    Current Clinical Pharmacology, Vol. 2, No. 2. (May 2007), pp. 123-128.
  • Clinical Trials: How to Assess Confounding and Why So
    Current Clinical Pharmacology, Vol. 2, No. 2. (May 2007), pp. 129-133.
  • Targeting Ion Channels for New Strategies in Cancer Diagnosis and Therapy
    Current Clinical Pharmacology, Vol. 2, No. 2. (May 2007), pp. 135-144.
  • Ethanol Metabolism and Effects: Nitric Oxide and its Interaction
    Current Clinical Pharmacology, Vol. 2, No. 2. (May 2007), pp. 145-153.
  • Clinical Efficacy and Effectiveness of Ursodeoxycholic Acid in Cholestatic Liver Diseases
    Current Clinical Pharmacology, Vol. 2, No. 2. (May 2007), pp. 155-177.
  • Open Questions on Bioequivalence: An Updated Reappraisal
    Current Clinical Pharmacology, Vol. 2, No. 2. (May 2007), pp. 179-189.
  • Misoprostol for the Treatment of Early Pregnancy Failure
    Current Clinical Pharmacology, Vol. 2, No. 1. (January 2007), pp. 1-9.
  • Warfarin Dosing and the Promise of Pharmacogenomics
    Current Clinical Pharmacology, Vol. 2, No. 1. (January 2007), pp. 11-21.
    by Dumas, E Todd, Hawke, L Roy, Lee, R Craig
    posted by 1 person balajis
  • Determinants of Drug Metabolism in Early Neonatal Life
    Current Clinical Pharmacology, Vol. 2, No. 1. (January 2007), pp. 23-29.
  • The True Face of the Revolution in Oncology Drug Development: A Personal Reflection
    Current Clinical Pharmacology, Vol. 2, No. 1. (January 2007), pp. 31-35.
  • Clinical Pharmacokinetics of Systemically Administered Antimycotics
    Current Clinical Pharmacology, Vol. 2, No. 1. (January 2007), pp. 37-58.
  • Immunomodulatory Therapy Associated to Anti-Parasite Drugs as a Way to Prevent Severe Forms of Malaria
    Current Clinical Pharmacology, Vol. 2, No. 1. (January 2007), pp. 59-73.
    by Imaculada Muniz-Junqueira, Maria
  • Busulphan in Blood and Marrow Transplantation: Dose, Route, Frequency and Role of Therapeutic Drug Monitoring
    Current Clinical Pharmacology, Vol. 2, No. 1. (January 2007), pp. 75-91.
    by Ellen Nath, Christa, John Shaw, Peter
  • The Pharmacogenetics of CYP2C9 and CYP2C19: Ethnic Variation and Clinical Significance
    Current Clinical Pharmacology, Vol. 2, No. 1. (January 2007), pp. 93-109.
  • Hypericin Lights Up the Way for the Potential Treatment of Nasopharyngeal Cancer by Photodynamic Therapy
    Current Clinical Pharmacology, Vol. 1, No. 3. (September 2006), pp. 217-222.
  • Sorafenib (BAY 43-9006): Review of Clinical Development
    Current Clinical Pharmacology, Vol. 1, No. 3. (September 2006), pp. 223-228.
  • Nuclear Imaging of Inflammation in Neurologic and Psychiatric Disorders
    Current Clinical Pharmacology, Vol. 1, No. 3. (September 2006), pp. 229-242.
    by De Vries, FJ Erik, Dierckx, A Rudi, Klein, C Hans
  • Pharmacologic Treatment of Rapid Ejaculation: Levels of Evidence-Based Review
    Current Clinical Pharmacology, Vol. 1, No. 3. (September 2006), pp. 243-254.
  • The Relevance of Microdialysis for Clinical Oncology
    Current Clinical Pharmacology, Vol. 1, No. 3. (September 2006), pp. 255-263.
  • Chronopharmacology and Antimicrobial Therapeutics
    Current Clinical Pharmacology, Vol. 1, No. 3. (September 2006), pp. 265-275.
  • Drug Susceptibility of the Mycobacterium Genus: In Vitro Tests and Clinical Implications
    Current Clinical Pharmacology, Vol. 1, No. 3. (September 2006), pp. 277-289.
  • Genetic and Environmental Influences on Therapeutic and Toxicity Outcomes: Studies with CYP2A6
    Current Clinical Pharmacology, Vol. 1, No. 3. (September 2006), pp. 291-309.
  • Clinical Pharmacokinetics of Irinotecan-Based Chemotherapy in Colorectal Cancer Patients
    Current Clinical Pharmacology, Vol. 1, No. 3. (September 2006), pp. 311-323.
  • The Imaging of Apoptosis with the Radiolabelled Annexin A5: A New Tool in Translational Research
    Current Clinical Pharmacology, Vol. 1, No. 2. (May 2006), pp. 129-137.
  • Clinical Experience with the Use of Angiotensin Receptor Blockers in Patients with Cardiovascular, Cerebrovascular and Renal Diseases
    Current Clinical Pharmacology, Vol. 1, No. 2. (May 2006), pp. 139-146.
  • The Case of Biotech-Derived Product Equivalence: Much Ado About Nothing?
    Current Clinical Pharmacology, Vol. 1, No. 2. (May 2006), pp. 147-156.
  • 注: このページを引用する時は次のURLでどうぞ: http://www.citeulike.org/journal/ben-ccp

    Result page: 1 2 Next RIS BibTeX
    CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.